Lord Walton of Detchant

To ask Her Majesty’s Government whether appropriate treatment for patients with plasma disorders such as haemophilia and primary immunodeficiency, as provided for under the statutory scheme for branded medicines, will continue to be provided following the

To ask Her Majesty’s Government why the acute adult dermatology service at Nottingham University Hospital is to be closed; and whether they have assessed the effect that that decision will have upon patients in the area affected by skin diseases.

To ask Her Majesty’s Government what effect they consider the loss of six consultant dermatologists in Nottingham will have upon direct services to the local community and the training of junior doctors and medical students.

To ask Her Majesty’s Government how they propose to respond to the survey of Acute Neurology Services issued by the Association of British Neurologists in December; and what action they plan to take to ensure that clearly defined quality standards in acut

To ask Her Majesty’s Government why they have withdrawn approval of the drug Translarna, introduced for the treatment of Duchenne muscular dystrophy, despite the preliminary results achieved in some patients in trials in Newcastle upon Tyne.